Intrauterine growth restriction

Tony Y T Tan1, George S H Yeo

  • 1Department of Maternal Fetal Medicine, KK Women's and Children's Hospital, Singapore.

Insights

Intrauterine growth restriction (IUGR) significantly impacts neonatal outcomes and long-term mental health. Optimal timing for delivery in IUGR fetuses, especially in monochorionic twins, remains a critical challenge in obstetrics.

Area of Science:

  • Obstetrics and Gynecology
  • Fetal Medicine
  • Neonatology

Background:

  • Intrauterine growth restriction (IUGR) is a significant obstetric complication with substantial neonatal mortality and morbidity.
  • IUGR is linked to long-term psychiatric sequelae, including depression and suicidal behaviors.

Purpose of the Study:

  • To review recent literature on intrauterine growth restriction.
  • To summarize current understanding and challenges in managing IUGR.

Main Methods:

  • Literature review of recent published studies on intrauterine growth restriction.
  • Analysis of findings related to fetal Doppler markers, delivery timing, and twin pregnancies.

Main Results:

  • Fetal Doppler changes in the ductus venosus and umbilical vein serve as markers for fetal academia.
  • Delayed delivery in IUGR fetuses up to 30 weeks may reduce cerebral palsy rates.
  • Selective fetocide in dichorionic twins with severe IUGR can prolong pregnancy.
  • Absent or reversed end-diastolic flow in monochorionic twins indicates increased risk of fetal death and brain damage.

Conclusions:

  • The optimal timing for delivery of preterm growth-restricted fetuses is still debated.
  • Assessing IUGR in monochorionic twins with abnormal umbilical artery Doppler flow presents diagnostic challenges.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...